Related Experiment Videos
Flow cytometric DNA analysis of thyroid carcinoma
A Tsuchiya1, K Sekikawa, Y Ando
1Second Department of Surgery, Fukushima Medical College, Japan.
Summary
Flowcytometric DNA analysis in thyroid carcinoma revealed that aneuploidy, or abnormal DNA content, is linked to decreased survival rates. While not a perfect predictor, DNA content aids in assessing tumor behavior and patient prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Abnormal DNA content is a potential marker for tumor biological behavior.
- Flow cytometry is a technique used to analyze DNA content in tumor cells.
Purpose of the Study:
- To investigate the incidence of aneuploidy in various types of thyroid carcinoma.
- To evaluate the correlation between DNA content, S-phase fraction, and patient survival in thyroid carcinoma.
Main Methods:
- Flowcytometric DNA analysis was performed on 121 thyroid carcinoma tissue samples from paraffin-embedded blocks.
- Histological classification included papillary, follicular, medullary, squamous cell, and anaplastic carcinomas.
- S-phase fraction was determined as a measure of proliferative potential.
Main Results:
- Aneuploidy was observed in 7.4% of thyroid carcinoma cases, with diploidy in 92.6%.
- Aneuploid specimens were found in papillary, follicular, medullary, and anaplastic carcinomas.
- Aneuploid patients exhibited a significantly decreased survival rate (p < 0.01).
- S-phase fraction was not found to be an independent prognostic factor.
Conclusions:
- DNA content analysis is useful for predicting the survival of aneuploid thyroid carcinoma patients.
- There is a correlation between DNA content and tumor biological behavior, though some discrepancies exist.
- Aneuploidy serves as an additional criterion for assessing the prognosis of thyroid carcinoma.